References
Reindl C, Bagrintseva K, Vempati S, Schnittger S, Ellwart JW, Wenig K, Hopfner KP, Hiddemann W, Spiekermann K (2006) Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML. Blood 107(9):3700–3707
Noguera NI, Breccia M, Divona M, Diverio D, Costa V, De Santis S, Avvisati G, Pinazzi MB, Petti MC, Mandelli F, Lo Coco F (2002) Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia 16:2185–2189
Stirewalt DL, Meshinchi S, Kussick SJ, Sheets KM, Pogosova-Agadjanyan E, Willman CL, Radich JP (2004) Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia. Br J Haematol 124(4):481–484
Syampurnawati M, Tatsumi E, Furuta K, Hayashi Y (2007) Four novel point mutations in exons 12, 13, and 14 of the FLT3 gene. Leuk Res 31(6):877
Stam RW, den Boer ML, Schneider P, Meier M, Beverloo HP, Pieters R (2007) D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia. Haematologica 92(11):1565–1568
Stubbs MC, Kim YM, Krivtsov AV, Wright RD, Feng Z, Agarwal J, Kung AL, Armstrong SA (2008) MLL-AF9 and FLT3 cooperation in acute myelogeneous leukemia: development of a model for rapid therapeutic assessment. Leukemia 22(1):66–77
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gianfelici, V., Diverio, D., Breccia, M. et al. A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia. Ann Hematol 90, 845–846 (2011). https://doi.org/10.1007/s00277-010-1092-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-010-1092-0